Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates Fri, May 10, 2024, 2:50 PM GMT+2 3 min read 0 In this article: Advertisement Up next Analyst adjusts Nvidia...
Deciphera Pharmaceuticals, Inc. (DCPH)
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
deciphera.com/investor-relations
Company Research
Source: Acquire Media Monitor
This compares to loss of $0.60 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 5.45%. A quarter ago, it was expected that this company would post a loss of $0.58 per share when it actually produced a loss of $0.54, delivering a surprise of 6.90%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Deciphera Pharmaceuticals , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $45 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 2.15%. This compares to year-ago revenues of $33.45 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Deciphera Ph
Show less
Read more
Impact Snapshot
Event Time:
DCPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DCPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DCPH alerts
High impacting Deciphera Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
DCPH
News
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, AGS, DCPHPR Newswire
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, HCP, DCPHPR Newswire
- Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER ALERT: Weiss Law Investigates Deciphera Pharmaceuticals, Inc.Accesswire
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, DPSI, UNITGlobeNewswire
DCPH
Earnings
- 5/10/24 - Beat
DCPH
Sec Filings
- 5/13/24 - Form SC
- 5/13/24 - Form SC
- 5/10/24 - Form 10-Q
- DCPH's page on the SEC website